Glycemic Control in Patients with Type 1 Diabetes Mellitus during COVID-19 Pandemic
Article Sidebar
Main Article Content
Abstract
This descriptive research aimed to study and compare the glycemic control in patients with type 1 diabetes mellitus before and during the COVID-19 pandemic. The samples were 96 patients with type 1 diabetes mellitus at ≥ 18 years and their primary caregivers at Siriraj Hospital, Bangkok, Thailand. The instruments included a questionnaire about personal data, self-management of diabetes and HbA1c record form. The content validity was tested by three experts. The content validity index (CVI) was 1.00. The data were analyzed by descriptive statistics, One-Way Repeated ANOVA, and McNemar test.
The findings revealed a continuous increase of HbA1c (Before the lockdowns = 8.50%, and during the first and the second lockdown = 8.61% and 8.94%, respectively). HbA1c between the second lockdown and before the lockdowns, as well as, the rate of uncontrolled blood sugar level between the second lockdown and the first lockdown showed a statistically significant difference. It was thus recommended undertaking further studies on the causes and factors influencing the glycemic control under emerging infectious disease situation to plan a suitable care for patients with type 1 diabetes mellitus.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Department of Disease Control. Corona virus disease (COVID-19) [Internet]. 2021 [cited 2021 Aug 10]. Available from: http://www.ratchakitcha.soc.go.th/DATA/PDF/2563/E/048/T_0001.PDF (in Thai)
Bumrungrad International Hospital. Eight groups of patients who infected with Covid-19 are at risk of having severe symptoms [Internet]. 2020 [cited 2021 Aug 10]. Available from: https://www.bumrungrad.com/th/health-blog/april-2020/covid-19-there-are-eight-risk-groups (in Thai)
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395(37):497-506.
Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes and Metabolic Syndrome 2020;14(3):211-2.
International Society for Pediatric and Adolescent Disease (ISPAD). Summary of recommendations regarding COVID-19 in children with diabetes [Internet]. 2020 [cited 2021 Aug 10]. Available from: https://www.ispad.org/page/CoronavirusinfectionCOVID-19-IIISPADSummary
Hosomi Y, Munekawa C, Hashimoto Y, Okamura T, Takahashi F, Kawano R, et al. The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetology International 2021;9(1):1-6.
Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes and Metabolic Syndrome 2020;14(5):917-20.
Thailand Development Research Institute. Impact of COVID-19 epidemic on family [Internet]. 2020 [cited 2021 Aug 10]. Available from: https://tdri.or.th/2020/08/covid19-impact-early-child/ (in Thai)
Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus. Diabetes and Metabolic Syndrome 2020;14(5):1213-6.
Chaiyata E, Numkham L, Rakkapao N. The relationship between health literacy, medication intake, and doctor’s appointment behavior among patients with diabetes mellitus and hypertension in Lamphun province. Thai Science and Technology Journal 2018;28(1):182-96. (in Thai)
Orem DE. Nursing: concepts of practice. Missouri CV: Mosby; 1995.
American Diabetes Association. Children and adolescents. Standards of medical care in diabetes-2021. Diabetes Care 2021;44(1):180-99.
Department of Disease Control. Corona virus disease (COVID-19) [Internet]. 2021 [cited 2021 Aug 10]. Available from: https://ddc.moph.go.th/viralpneumonia/file/situation/situation-no354-221263.pdf (in Thai)
Wu X, Luo S, Zheng X, Ding Y, Wang S, Ling P, et al. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: a continuous glucose monitoring-based observational study. Journal of Diabetes Investigation 2021;12(9):1708-17.
Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes and Metabolic Syndrome 2020;14(5):965-7.
Liu CJ, Chiu HY, Hui CY, Lin KC, Huang HC. Effects of mobile health interventions on improving glycemic stability and quality of life in patients with type 1 diabetes: a meta-analysis. Research in Nursing and Health 2021;44(1):187-200.